AngioDynamics Reports Fiscal 2020 Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
AngioDynamics (ANGO) Tops Q3 EPS by 4c, Revenues Beat
April 7, 2020 7:02 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.01, $0.04 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $69.8 million versus the consensus estimate of $68.55 million.
Third Quarter 2020 Financial Results
Net sales for the third quarter of fiscal 2020 were $69.8 million, an increase of 6.5% compared to the prior-year quarter. Excluding the impact of Asclera sales, which were discontinued during fiscal year 2019, net sales grew 9.3% year over year. Foreign currency translation did not have a significant impact on the Companys sales in the quarter.
Oncology net sales were $14.6 million, an... More